Manufacturer record
Bajaj Healthcare Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Bajaj Healthcare Ltd (Gujarat) were declared Not of Standard Quality between May 2024 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DFA03G25, Deferasirox Dispersible Tablets 100mg (exp Jun 2027). CDL Kolkata (CDSCO lab) found it not of standard quality: The sample is declared to be not of standard quality for the reason stated under Description and as it does not conform to Manufacturer's. Listed in the June 2026 alert.
Records by type
6 records linked to Bajaj Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Deferasirox Dispersible Tablets 100mg | Batch DFA03G25Mfg Jul 2025 · Exp Jun 2027 | The sample is declared to be not of standard quality for the reason stated under Description and as it does not conform to Manufacturer's Specification with respect to the tests of Hardness and Friability.Description | CDL KolkataCDSCO lab | Jun 2026 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | Batch ASB07J24Mfg Oct 2024 · Exp Sep 2026 | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | Batch TLB06E24Mfg May 2024 · Exp Apr 2026 | DissolutionDissolution | SDTL, VijayawadaState lab | Feb 2026 |
| Sacubitril and Valsartan Tablets 50 mg (SVJAJ 50) | Batch SVA04H24CMfg Aug 2024 · Exp Jul 2026 | "Assay"/ content of "Sacubitril" and "Valsartan"Assay | CDTL-MumbaiCDSCO lab | Mar 2025 |
| Hydroxychloroqui ne Sulphate Tableta IP 200 mg (QUEENJAJ 200) | Batch HCQ19K23Mfg Nov 2023 · Exp Oct 2026 | "Related substances"Related substances | CDTL MumbaiCDSCO lab | Dec 2024 |
| Vildagliptinand Metformin Hydrochloride Tablets IP 50mg/1000mg | Batch VMC04G 23AMfg Oct 2023 · Exp Sep 2025 | The sample does not conform to IP with respect to the test for Dissolution and Assay of Vildagliptin.Assay | CDL KolkataCDSCO lab | May 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.